NCT03498872

Brief Summary

Objectives: The main objectives are to determine neural dynamics during gait using electro-encephalography as well as brain sources and to investigate the attentional demand during walking in able-bodied individuals, and individuals with an amputation. Materials \& Methods: 6 able-bodied individuals conducted one experimental trial, and 6 unilateral transtibial and 6 unilateral transfemoral amputees performed 2 experimental trials; the first with the current and the second with a novel powered transtibial prosthesis, i.e. the Ankle Mimicking Prosthetic foot 4.0. Each experimental trial comprised 2 walking tasks; 6 and 2min treadmill walking at normal speed interspersed by 5min of rest. During 6min walking the sustained attention to response (go-no go) task, with measures reaction time and accuracy, was performed. Electro-encephalographic (EEG) data were gathered when subjects walked 2min. Motor-related cortical potentials and brain activity during gait are extracted using EEG.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2016

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 3, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 17, 2018

Completed
Last Updated

April 17, 2018

Status Verified

April 1, 2018

Enrollment Period

3 months

First QC Date

April 3, 2018

Last Update Submit

April 13, 2018

Conditions

Keywords

AMPfootProstheticsgaitelectro-encephalographydual-task walking

Outcome Measures

Primary Outcomes (3)

  • Reaction time (in ms) of responses during go - no go cognitive task

    Time between visual stimulus and motor response (pushing button)

    Through study completion, a period of 2 months

  • Accuracy (in percentage) of correct responses during go - no go cognitive task

    Accuracy of motor responses to visual stimuli

    Through study completion, a period of 2 months

  • EEG extracted brain signals, i.e. motor-related cortical potentials

    Non-invasive electro-encephalography was used to determine electro-cortical potentials and brain sources of these potentials

    Through study completion, a period of 2 months

Study Arms (3)

Able-bodied individuals

ACTIVE COMPARATOR
Other: No intervention

Transtibial amputee

EXPERIMENTAL
Device: AMPfoot 4.0

Transfemoral amputee

EXPERIMENTAL
Device: AMPfoot 4.0

Interventions

The novel prosthetic device, i.e. AMPfoot 4.0, was tested during walking in amputees. A dual-task was conducted and non-invasive electro-encephalography was used to investigate neural dynamics.

Transfemoral amputeeTranstibial amputee

The control group included healthy subjects. Comparisons were made between amputees and able-bodied individuals.

Able-bodied individuals

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral transfemoral amputees
  • Unilateral transtibial amputees
  • Able-bodied individuals

You may not qualify if:

  • Children
  • Functional k-level lower than 4 (Amputee has the ability for prosthetic ambulation that exceeds basic ambulation skills, exhibiting high impact, stress or energy levels)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vrije Universiteit Brussel

Brussels, Vlaams Brabant, 1050, Belgium

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

April 3, 2018

First Posted

April 17, 2018

Study Start

October 1, 2016

Primary Completion

December 15, 2016

Study Completion

December 15, 2016

Last Updated

April 17, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations